<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27313390</article-id><article-id pub-id-type="pmc">4905929</article-id><article-id pub-id-type="publisher-id">jpts-2015-1106</article-id><article-id pub-id-type="doi">10.1589/jpts.28.1644</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison between two physiotherapy protocols for patients with chronic
kidney disease on dialysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Neto</surname><given-names>Jos&#x000e9; Roberto Sostena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Figueiredo e Castro</surname><given-names>Let&#x000ed;cia Magalh&#x000e3;es</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Santos de Oliveira</surname><given-names>Fernanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Andr&#x000e9;ia Maria</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Maria dos Reis</surname><given-names>Luciana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Quirino</surname><given-names>Ana Paula Assun&#x000e7;&#x000e3;o</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dragosavac</surname><given-names>Desanka</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kosour</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1)</label> Nursing Department, Federal University of Alfenas,
Alfenas-MG, Brazil</aff><aff id="aff2"><label>2)</label> Hospital Casa da Caridade Alfenas Nossa Senhora do Perp&#x000e9;tuo
Socorro, Brazil</aff><aff id="aff3"><label>3)</label> Division of Physiology and Metabology in Surgery,
Department of Surgery, Medical Sciences Faculty, State University of Campinas,
Brazil</aff><aff id="aff4"><label>4)</label> Federal University of Alfenas (Unifal), Brazil</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Carolina Kosour, Federal University of Alfenas (Unifal): Jovino Fernandes
Sales Av., 2600-Building A, 37130-000, Alfenas-MG, Brazil. (E-mail: <email xlink:href="carolina.kosour@unifal-mg.edu.br">carolina.kosour@unifal-mg.edu.br</email>)</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2016</year></pub-date><volume>28</volume><issue>5</issue><fpage>1644</fpage><lpage>1650</lpage><history><date date-type="received"><day>18</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>2016&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] To compare the effects of two physiotherapy protocols for chronic kidney
disease patients on dialysis. [Subjects and Methods] This is a prospective, randomized
study, in chronic kidney disease patients 18&#x02005;years of age or older on dialysis. Sessions
for each group (were conducted three times per week for a total of 10 sessions), during
hemodialysis. Respiratory muscle strength (maximal inspiratory and expiratory pressure),
peak expiratory flow, and peripheral muscle strength were evaluated. The study group
received motor and respiratory physiotherapy, and the control group received motor
physiotherapy alone. [Results] We observed a significant increase in the maximal
inspiratory pressure in the study group in the 5th and 10th sessions and in the maximal
expiratory pressure in the 1st session, peak flow in the 1st and 10th sessions, and
dynamometry in the 10th session. In the control group, there was a significant decrease in
maximal inspiratory pressure in the 5th and 10th sessions, and in maximal expiratory
pressure in the 10th session, peak flow in the 5th and 10th sessions, and dynamometry in
the 5th session. [Conclusion] Implementation of motor physiotherapy combined with
respiratory physiotherapy may have contributed to the improvement of the variables
analyzed in the study group.</p></abstract><kwd-group><title>Key words</title><kwd>Renal failure</kwd><kwd>Renal dialysis</kwd><kwd>Physiotherapy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Chronic kidney disease (CKD) has a high morbidity and mortality rate. More than one million
people require hemodialysis and kidney transplantation annually<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>.</p><p>CKD is defined as a slowly progressive and irreversible loss of kidney function, leading to
a condition in which the kidneys are no longer able to function due to destruction of the
nephrons, which reduces the ability of the body to sustain metabolic and hydroelectrolytic
renal equilibrium. Kidney dysfunction is considered to occur when the glomerular filtration
rate (GFR) falls below 60&#x02005;ml/min/1.73 m<sup>2</sup>, for longer than three months, and, end
stage CKD occurs when the GFR falls below 15&#x02005;ml/min/1.73 m<sup>2</sup>. In this stage,
hemodialysis (HD) is used to compensate for the reduced renal function. However, despite
technological advancements, patients still have dysfunctions such as anemia, cardiomyopathy,
depression, systemic arterial hypertension, metabolic and respiratory alterations, early
fatigue, mental compromise, peripheral circulatory deficits, and mental and muscular
alterations, thus reducing their quality of life<xref rid="r2" ref-type="bibr">2</xref>,
<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>.</p><p>It is known that a loss of muscle mass is associated with morbidity and mortality. The
quantity of muscle fibers is strongly correlated with muscle strength, muscular oxygen
extraction, and functional capacity in dialysis patients<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>.</p><p>The muscles responsible for respiration, the diaphragm and intercostal muscles, are
classified as skeletal muscles and can experience decreases in endurance and strength. Other
pulmonary complications in chronic renal failure (CRF) patients include pulmonary edema,
pleural effusion (mainly in terminal CRF patients), fibrosis, pulmonary and pleural
calcification, pulmonary hypertension, capillary and pulmonary blood flow decreases, and
hypoxemia<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>.</p><p>Therefore, patients with CKD have less physical and functional capacity than the general
population, and HD treatment limits the activity of these patients, which exacerbates
functional limitations<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>.</p><p>Accordingly, physiotherapy programs have been proposed that aim not only to treat the
clinical manifestations of the disease but also the adverse effects on cardiorespiratory and
muscular function, the quality of life, would be enhanced by improving metabolic,
physiological and psychological conditions. The literature shows that physiotherapy, during
the intradialytic period and during the intermission between sessions in CRF patients
produces better functional literature shows that physiotherapy, during the intradialytic
period and during, the intermission between sessions in CRF capacity, blood pressure
control, cardiac function, and muscular strength and resistance, in addition to being a
motivational factor and providing a break from the monotony of treatment, which can be an
effective psychosocial intervention. The practice of regular physical exercise decreases the
prevalence of associated diseases and systemic complications<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>However, there are no reports in the literature showing the superiority of any
physiotherapy protocol used in patients with CKD on HD. The present study aims to compare
two physiotherapy protocols applied inchronic renal patients during HD treatment.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>All participants were informed about the experimental procedures and provided signed
informed consent. This was a prospective randomized clinical study. The patients were
allocated into a study group and a control group. The effects of two physiotherapy protocols
were compared in patients with CKD (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Study flowchart</p></caption><graphic xlink:href="jpts-28-1644-g001"/></fig>).</p><p>The initial sample consisted of 22 patients with CKD on HD; however, two patients
discontinued participation in the study. The inclusion criteria for participation consisted
of the following: either gender, between 18 and 70&#x02005;years old, patients at Hospital Casa de
Caridade Alfenas Nossa Senhora do Perp&#x000e9;tuo Socorro, Hemodialysis Section; HD three times per
week, using a bicipital fistula for access.</p><p>Patients were excluded from the study if they had hemodynamic instability, pathologic
fractures, cognitive deficits including uncoordinated use of an gadgets, uncontrolled
diabetes mellitus (DM) or systemic arterial hypertension (SAH), or systemic diseases other
than DM, SAH, and CKD.</p><p>All of the patients involved in the study were assisted by the same medical, nursing, and
physiotherapy team.</p><p><bold>S</bold>essions were conducted (three times per week, for a total of 10 sessions) for
each group during dialysis treatment. The patients were informed of the evaluation
procedures and physiotherapy protocols during the study.</p><p>The patients were evaluated before and after the 1st, 5th, and 10th physiotherapy
sessions.</p><p>The measured variables included the following:</p><p>-Respiratory Muscle Strength. At the beginning of the measurement, individuals were
instructed to maintain mouth pressure to measure the maximal expiration capacity for 1.5&#x02005;s
to determine the maximal inspiratory pressure (MIP); then, maximal inspiration was measured
for 1.5&#x02005;s to determine the maximal expiratory pressure (MEP). The measures were repeated
three times, and the highest value was used.</p><p>-Expiratory Peak Flow &#x02212; This was measured with a PeakFlow Meter<sup>&#x000ae;</sup> Mini-wright
Adult 3103. Expiratory, provided by the Federal University of Alfenas &#x02212; MG UNIFAL. Peak flow
was measured in a seated position to reduce obstruction of the upper airways. Three
measurements were conducted, and the highest value was used.</p><p>-Peripheral Muscle Strength. This was measured with a hand-held hydraulic dynamometer
(SAEHAN<sup>&#x000ae;</sup>-SH5001) provided by the Federal University of Alfenas &#x02212; MG UNIFAL.
Measurements were conducted with the patient seated, and the elbow of the arm without the
fistula in 90&#x000b0; of flexion; the patient was asked to use maximal manual grip strength.
Measurements were repeated three times, and the highest value was used.</p><p>-The respiratory frequency (RF), heart rate (HR), and systemic arterial pressure (AP) were
measured before and after the physiotherapy sessions.</p><p>The physiotherapy protocols were conducted five&#x02005;min after the beginning of HD, with the
approval of the physician and the responsible nurse on duty; the duration of the session was
40&#x02005;min.</p><p>In the study group protocol, more structured and individualized procedures were conducted
including motor physiotherapy with cervical mobilization (stretching, flexion, extension,
lateral inclination, and rotation), upper limb (UL) exercises (shoulder, elbow, and fist
flexion and extension), and lower limb (LL) exercises (flexion, extension, abduction and
adduction) for 30&#x02005;s for each series. Respiratory physiotherapy included exercises that
utilized a Respiron<sup>&#x000ae;</sup> inspirometer provided by the Federal University of Alfenas &#x02212;
MG UNIFAL, for exercises involving the,diaphragmatic respiratory pattern that were conducted
in three sets of five repetitions. Metabolic exercises included dorsiflexion and plantar
flexion with the patient seated. Fifteen repetitions were performed for each limb.</p><p>The protocol in the control group consisted of motor physiotherapy, including mobilization
and stretching of the cervical area (flexion, extension, lateral inclination and rotation),
UL (shoulder, elbow, and fist flexion and extension), and LL (flexion, extension, abduction,
and adduction), all protocols were conducted in 30&#x02005;s series.</p><p>The Shapiro-Wilk test was used to determine data homogeneity. Independent t-tests and
Mann-Whitney tests were used to compare variables between groups before the intervention.
Paired t-tests and Wilcoxon tests were used for intragroup comparisons after the 1st, 5th
and 10th and session. Two-way analysis of variance (ANOVA) was used for intergroup
comparisons. Pearson&#x02019;s test was used to determine the correlation between respiratory
variables and peripheral muscle strength. Statistical significance was determined by a value
of p&#x0003c;0.05.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>No significant differences were found between the groups for gender (p=0.49) and age
(p=0.59). <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Pre-intervention intergroup comparison of variables.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Study group</th><th align="center" rowspan="1" colspan="1">Control group </th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Preintervention</th><th align="center" rowspan="1" colspan="1">Preintervention</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">HR (beats/min)</td><td align="center" rowspan="1" colspan="1">85.1 &#x000b1; 16.2</td><td align="center" rowspan="1" colspan="1">82.7 &#x000b1; 18.9</td></tr><tr><td align="center" rowspan="1" colspan="1">73.4&#x02013;96.7</td><td align="center" rowspan="1" colspan="1">69.1&#x02013;96.2</td></tr><tr><td align="left" rowspan="2" colspan="1">RF (times/min)</td><td align="center" rowspan="1" colspan="1">20.9 &#x000b1; 4.9</td><td align="center" rowspan="1" colspan="1">23.4 &#x000b1; 8.9</td></tr><tr><td align="center" rowspan="1" colspan="1">17.3&#x02013;24.4</td><td align="center" rowspan="1" colspan="1">17.0&#x02013;29.7</td></tr><tr><td align="left" rowspan="2" colspan="1">PO<sub>2</sub>S (%)</td><td align="center" rowspan="1" colspan="1">95.2 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">95.4 &#x000b1; 2.5</td></tr><tr><td align="center" rowspan="1" colspan="1">93.2&#x02013;97.1</td><td align="center" rowspan="1" colspan="1">93.5&#x02013;97.2</td></tr><tr><td align="left" rowspan="2" colspan="1">MIP (mmHg)</td><td align="center" rowspan="1" colspan="1">61.6 &#x000b1; 26.9</td><td align="center" rowspan="1" colspan="1">59.6 &#x000b1; 20.1</td></tr><tr><td align="center" rowspan="1" colspan="1">42.3&#x02013;80.8</td><td align="center" rowspan="1" colspan="1">45.1&#x02013;74.0</td></tr><tr><td align="left" rowspan="2" colspan="1">MEP (mmHg)</td><td align="center" rowspan="1" colspan="1">78.8 &#x000b1; 25.5</td><td align="center" rowspan="1" colspan="1">90.4 &#x000b1; 26.0</td></tr><tr><td align="center" rowspan="1" colspan="1">60.5&#x02013;97.0</td><td align="center" rowspan="1" colspan="1">71.7&#x02013;109.0</td></tr><tr><td align="left" rowspan="2" colspan="1">PEAKFLOW (ml)</td><td align="center" rowspan="1" colspan="1">358.0 &#x000b1; 130.1</td><td align="center" rowspan="1" colspan="1">392.0 &#x000b1; 132.9</td></tr><tr><td align="center" rowspan="1" colspan="1">264.8&#x02013;451.1</td><td align="center" rowspan="1" colspan="1">296.8&#x02013;487.1</td></tr><tr><td align="left" rowspan="2" colspan="1">DYNAMOMETER (kg)</td><td align="center" rowspan="1" colspan="1">22.4 &#x000b1; 9.1</td><td align="center" rowspan="1" colspan="1">29.2 &#x000b1; 10.8</td></tr><tr><td align="center" rowspan="1" colspan="1">15.8&#x02013;28.9</td><td align="center" rowspan="1" colspan="1">21.4&#x02013;36.9</td></tr></tbody></table><table-wrap-foot><p>HR: Heart Rate; RF: Respiratory Frequency; PO<sub>2</sub>S: Peripheral Oxygen
Saturation; MIP: Maximal Inspiratory Pressure; MEP: Maximal Expiratory Pressure;
PeakFlow: &#x00395;xpiratory Peak Flow; Dynamometer: Peripheral Muscular Strength.</p></table-wrap-foot></table-wrap> shows that no significant differences were observed between the study and
control groups during the pre-intervention period, thus showing that they were matched
comparison groups.</p><p><xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Mean, standard deviation, and confidence intervals of the variables at the 1st,
5th, and 10th sessions for the study group (SG)</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="9" align="left" colspan="1"/><th colspan="6" align="center" rowspan="1">SG (n=10)</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">1st Session</th><th colspan="2" align="center" rowspan="1">5th Session</th><th colspan="2" align="center" rowspan="1">10th Session</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">CI</th><th colspan="2" align="center" rowspan="1">CI</th><th colspan="2" align="center" rowspan="1">CI</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">HR (beats/min)</td><td align="center" rowspan="1" colspan="1">85.1 &#x000b1; 16.2</td><td align="center" rowspan="1" colspan="1">77.6 &#x000b1; 9.6</td><td align="center" rowspan="1" colspan="1">82.9 &#x000b1; 12.2</td><td align="center" rowspan="1" colspan="1">79.6 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">83.9 &#x000b1; 73.4</td><td align="center" rowspan="1" colspan="1">76.8 &#x000b1; 15.2 </td></tr><tr><td align="center" rowspan="1" colspan="1">73.4&#x02013;96.7</td><td align="center" rowspan="1" colspan="1">70.6&#x02013;84.5</td><td align="center" rowspan="1" colspan="1">74.1&#x02013;91.6</td><td align="center" rowspan="1" colspan="1">72.4&#x02013;86.7</td><td align="center" rowspan="1" colspan="1">70.8&#x02013;94.3</td><td align="center" rowspan="1" colspan="1">65.8&#x02013;87.7*</td></tr><tr><td align="left" rowspan="2" colspan="1">RF (times/min)</td><td align="center" rowspan="1" colspan="1">20.9 &#x000b1; 4.9</td><td align="center" rowspan="1" colspan="1">19.6 &#x000b1; 5.5</td><td align="center" rowspan="1" colspan="1">19.7 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">17.9 &#x000b1; 5.5</td><td align="center" rowspan="1" colspan="1">21.3 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">19.1 &#x000b1; 6.0</td></tr><tr><td align="center" rowspan="1" colspan="1">17.3&#x02013;24.4</td><td align="center" rowspan="1" colspan="1">15.6&#x02013;23.5</td><td align="center" rowspan="1" colspan="1">15.4&#x02013;23.9</td><td align="center" rowspan="1" colspan="1">13.9&#x02013;21.8*</td><td align="center" rowspan="1" colspan="1">16.5&#x02013;26.0</td><td align="center" rowspan="1" colspan="1">14.7&#x02013;23.4*</td></tr><tr><td align="left" rowspan="2" colspan="1">PO<sub>2</sub>S (%)</td><td align="center" rowspan="1" colspan="1">95.2 &#x000b1; 2.74</td><td align="center" rowspan="1" colspan="1">97.2 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">95.5 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">97.6 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">94.7 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">98.0 &#x000b1; 0.4 </td></tr><tr><td align="center" rowspan="1" colspan="1">93.2&#x02013;97.1</td><td align="center" rowspan="1" colspan="1">95.4&#x02013;98.9</td><td align="center" rowspan="1" colspan="1">94.0&#x02013;96.9</td><td align="center" rowspan="1" colspan="1">96.9&#x02013;98.2</td><td align="center" rowspan="1" colspan="1">92.4&#x02013;96.9</td><td align="center" rowspan="1" colspan="1">97.6&#x02013;98.3*</td></tr><tr><td align="left" rowspan="2" colspan="1">MIP (mmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">61.6 &#x000b1; 26.9</td><td align="center" rowspan="1" colspan="1">70.0 &#x000b1; 21.0</td><td align="center" rowspan="1" colspan="1">73.6 &#x000b1; 20.5</td><td align="center" rowspan="1" colspan="1">79.2 &#x000b1; 22.0</td><td align="center" rowspan="1" colspan="1">75.6 &#x000b1; 26.8</td><td align="center" rowspan="1" colspan="1">83.6 &#x000b1; 25.7 </td></tr><tr><td align="center" rowspan="1" colspan="1">42.3&#x02013;80.8</td><td align="center" rowspan="1" colspan="1">54.9&#x02013;85.0</td><td align="center" rowspan="1" colspan="1">58.8&#x02013;88.3</td><td align="center" rowspan="1" colspan="1">63.4&#x02013;94.9*</td><td align="center" rowspan="1" colspan="1">56.3&#x02013;94.8</td><td align="center" rowspan="1" colspan="1">65.1&#x02013;102.0*</td></tr><tr><td align="left" rowspan="2" colspan="1">MEP (mmH<sub>2</sub>O)</td><td align="center" rowspan="1" colspan="1">78.8 &#x000b1; 25.5</td><td align="center" rowspan="1" colspan="1">90.0 &#x000b1; 25.5 </td><td align="center" rowspan="1" colspan="1">101.6 &#x000b1; 21.9</td><td align="center" rowspan="1" colspan="1">102.8 &#x000b1; 22.9</td><td align="center" rowspan="1" colspan="1">105.6 &#x000b1; 18.4</td><td align="center" rowspan="2" colspan="1">107.6 &#x000b1; 17.7 94.9&#x02013;120.6</td></tr><tr><td align="center" rowspan="1" colspan="1">60.5&#x02013;97.0</td><td align="center" rowspan="1" colspan="1">71.7&#x02013;108.2*</td><td align="center" rowspan="1" colspan="1">85.9&#x02013;117.2</td><td align="center" rowspan="1" colspan="1">86.3&#x02013;119.2</td><td align="center" rowspan="1" colspan="1">92.3&#x02013;118.8</td></tr><tr><td align="left" rowspan="2" colspan="1">PEAKFLOW (ml)</td><td align="center" rowspan="1" colspan="1">358.0 &#x000b1; 130.9</td><td align="center" rowspan="1" colspan="1">400.0 &#x000b1; 109.9 </td><td align="center" rowspan="1" colspan="1">398.0 &#x000b1; 98.0</td><td align="center" rowspan="1" colspan="1">413.0 &#x000b1; 94.0</td><td align="center" rowspan="1" colspan="1">403.0 &#x000b1; 106.3</td><td align="center" rowspan="1" colspan="1">421.0 &#x000b1; 97.6</td></tr><tr><td align="center" rowspan="1" colspan="1">264.8&#x02013;451.1</td><td align="center" rowspan="1" colspan="1">321.3&#x02013;478.6*</td><td align="center" rowspan="1" colspan="1">327.8&#x02013;468.1</td><td align="center" rowspan="1" colspan="1">345.7&#x02013;480.2</td><td align="center" rowspan="1" colspan="1">326.9&#x02013;479.0</td><td align="center" rowspan="1" colspan="1">351.1&#x02013;490.8*</td></tr><tr><td align="left" rowspan="2" colspan="1">DYNAMOMETER (kg)</td><td align="center" rowspan="1" colspan="1">22.4 &#x000b1; 9.1</td><td align="center" rowspan="1" colspan="1">22.6 &#x000b1; 8.3</td><td align="center" rowspan="1" colspan="1">23.2 &#x000b1; 11.7</td><td align="center" rowspan="1" colspan="1">23.2 &#x000b1; 10.3</td><td align="center" rowspan="1" colspan="1">23.4 &#x000b1; 11.0</td><td align="center" rowspan="1" colspan="1">25.2 &#x000b1; 11.0</td></tr><tr><td align="center" rowspan="1" colspan="1">15.8&#x02013;28.9</td><td align="center" rowspan="1" colspan="1">16.6&#x02013;28.5</td><td align="center" rowspan="1" colspan="1">14.8&#x02013;31.5</td><td align="center" rowspan="1" colspan="1">15.7&#x02013;30.6</td><td align="center" rowspan="1" colspan="1">15.5&#x02013;31.2</td><td align="center" rowspan="1" colspan="1">17.3&#x02013;33.0*</td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05; SD: standard deviation; CI: confidence interval; HR: Heart Rate; RF:
Respiratory Frequency; PO<sub>2</sub>S: Peripheral Oxygen Saturation; MIP: Maximal
Inspiratory Pressure; MEP: Maximal Expiratory Pressure; PeakFlow: Expiratory Peak
Flow; Dynamometer: Peripheral Muscular Strength.</p></table-wrap-foot></table-wrap> shows significant increases (in the MEP and MIP) in the study group after the
protocol, including MEP (p=0.02) and peak flow (p=0.00) relative to the 1st session; CF
(p=0.01) and MIP (p=0.00) relative to the 5th session; and HR (p=0.00), RF (p=0.01), MIP
(p=0.01), peak flow (p=0.04), and dynamometry (p=0.00) relative to the 10th session using
the paired t-test and Wilcoxon test.</p><p><xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Mean, standard deviation and confidence intervals of the variables concerning the
1st, 5th and 10th session for the control group (CG)</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="9" align="left" colspan="1"/><th colspan="6" align="center" rowspan="1">CG (n=10)</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">1st session</th><th colspan="2" align="center" rowspan="1">5th session</th><th colspan="2" align="center" rowspan="1">10th session</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After </th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th><th colspan="2" align="center" rowspan="1">Mean &#x000b1; SD</th></tr><tr><th colspan="6" rowspan="1"><hr/></th></tr><tr><th colspan="2" align="center" rowspan="1">CI</th><th colspan="2" align="center" rowspan="1">CI</th><th colspan="2" align="center" rowspan="1">CI</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">CF (beats/min)</td><td align="center" rowspan="1" colspan="1">82.7 &#x000b1; 18.9 </td><td align="center" rowspan="1" colspan="1">78.2 &#x000b1; 15.8 </td><td align="center" rowspan="1" colspan="1">90.0 &#x000b1; 13.5 </td><td align="center" rowspan="1" colspan="1">77.7 &#x000b1; 14.0 </td><td align="center" rowspan="1" colspan="1">78.6 &#x000b1; 15.4 </td><td align="center" rowspan="1" colspan="1">78.8 &#x000b1; 14.7 </td></tr><tr><td align="center" rowspan="1" colspan="1">69.1&#x02013;96.2</td><td align="center" rowspan="1" colspan="1">66.8&#x02013;89.5</td><td align="center" rowspan="1" colspan="1">80.3&#x02013;99.6</td><td align="center" rowspan="1" colspan="1">67.6&#x02013;87.7*</td><td align="center" rowspan="1" colspan="1">67.5&#x02013;89.6</td><td align="center" rowspan="1" colspan="1">68.2&#x02013;89.3</td></tr><tr><td align="left" rowspan="2" colspan="1">RF (times/min)</td><td align="center" rowspan="1" colspan="1">23.4 &#x000b1; 8.9 </td><td align="center" rowspan="1" colspan="1">24.2 &#x000b1; 7.3 </td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 5.8 </td><td align="center" rowspan="1" colspan="1">20.9 &#x000b1; 7.4 </td><td align="center" rowspan="1" colspan="1">20.1 &#x000b1; 6.2</td><td align="center" rowspan="1" colspan="1">20.9 &#x000b1; 3.9 </td></tr><tr><td align="center" rowspan="1" colspan="1">17.0&#x02013;29.7</td><td align="center" rowspan="1" colspan="1">18.9&#x02013;29.4</td><td align="center" rowspan="1" colspan="1">16.0&#x02013;24.3</td><td align="center" rowspan="1" colspan="1">15.5&#x02013;26.2</td><td align="center" rowspan="1" colspan="1"> 15.6&#x02013;24.5</td><td align="center" rowspan="1" colspan="1">18.0&#x02013;23.7</td></tr><tr><td align="left" rowspan="2" colspan="1">PO<sub>2</sub>S (%)</td><td align="center" rowspan="1" colspan="1">95.4 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">95.9 &#x000b1; 2.6 </td><td align="center" rowspan="1" colspan="1">96.1 &#x000b1; 2.5 </td><td align="center" rowspan="1" colspan="1">96.2 &#x000b1; 1.5 </td><td align="center" rowspan="1" colspan="1">96.3 &#x000b1; 2.0 </td><td align="center" rowspan="1" colspan="1">94.2 &#x000b1; 2.9 </td></tr><tr><td align="center" rowspan="1" colspan="1">93.5&#x02013;97.2</td><td align="center" rowspan="1" colspan="1">94.0&#x02013;97.7</td><td align="center" rowspan="1" colspan="1">94.3&#x02013;97.8</td><td align="center" rowspan="1" colspan="1">95.0&#x02013;97.3</td><td align="center" rowspan="1" colspan="1">94.8&#x02013;97.7</td><td align="center" rowspan="1" colspan="1">92.0&#x02013;96.3</td></tr><tr><td align="left" rowspan="2" colspan="1">MIP (mmHg)</td><td align="center" rowspan="1" colspan="1">59.6 &#x000b1; 20.1 </td><td align="center" rowspan="1" colspan="1">63.6 &#x000b1; 29.0 </td><td align="center" rowspan="1" colspan="1">86.4 &#x000b1; 26.4 </td><td align="center" rowspan="1" colspan="1">79.6 &#x000b1; 27.3 </td><td align="center" rowspan="1" colspan="1">86.8 &#x000b1; 24.5 </td><td align="center" rowspan="1" colspan="1">78.4 &#x000b1; 25.6</td></tr><tr><td align="center" rowspan="1" colspan="1">45.1&#x02013;74.0</td><td align="center" rowspan="1" colspan="1">42.8&#x02013;84.3</td><td align="center" rowspan="1" colspan="1">67.4&#x02013;105.3</td><td align="center" rowspan="1" colspan="1">60.0&#x02013;99.1*</td><td align="center" rowspan="1" colspan="1">69.2&#x02013;104.3</td><td align="center" rowspan="1" colspan="1">60.0&#x02013;96.7*</td></tr><tr><td align="left" rowspan="2" colspan="1">MEP(mmHg)</td><td align="center" rowspan="1" colspan="1">90.4 &#x000b1; 26.0 </td><td align="center" rowspan="1" colspan="1">86.4 &#x000b1; 30.2 </td><td align="center" rowspan="1" colspan="1">104.0 &#x000b1; 23.3 </td><td align="center" rowspan="1" colspan="1">99.6 &#x000b1; 24.4 </td><td align="center" rowspan="1" colspan="1">106.8 &#x000b1; 19.0 </td><td align="center" rowspan="1" colspan="1">102.0 &#x000b1; 22.7 </td></tr><tr><td align="center" rowspan="1" colspan="1">71.7&#x02013;109.0</td><td align="center" rowspan="1" colspan="1">64.7&#x02013;108.0</td><td align="center" rowspan="1" colspan="1">87.3&#x02013;120.6</td><td align="center" rowspan="1" colspan="1">82.1&#x02013;117.0</td><td align="center" rowspan="1" colspan="1">93.1&#x02013;120.4</td><td align="center" rowspan="1" colspan="1">85.7&#x02013;118.2*</td></tr><tr><td align="left" rowspan="2" colspan="1">PEAKFLOW (ml)</td><td align="center" rowspan="1" colspan="1">392.0 &#x000b1; 132.9</td><td align="center" rowspan="1" colspan="1">415.0 &#x000b1; 140.2</td><td align="center" rowspan="1" colspan="1">446.0 &#x000b1; 116.9</td><td align="center" rowspan="1" colspan="1">427.0 &#x000b1; 121.2</td><td align="center" rowspan="1" colspan="1">447.0 &#x000b1; 118.8</td><td align="center" rowspan="1" colspan="1">422.0 &#x000b1; 112.3</td></tr><tr><td align="center" rowspan="1" colspan="1">296.8&#x02013;487.1</td><td align="center" rowspan="1" colspan="1">314.6&#x02013;515.3</td><td align="center" rowspan="1" colspan="1">362.3&#x02013;529.6</td><td align="center" rowspan="1" colspan="1">340.2&#x02013;513.7*</td><td align="center" rowspan="1" colspan="1">361.9&#x02013;532.0</td><td align="center" rowspan="1" colspan="1">334.4&#x02013;509.5*</td></tr><tr><td align="left" rowspan="2" colspan="1">DYNAMOMETER (Kg)</td><td align="center" rowspan="1" colspan="1">29.2 &#x000b1; 10.8</td><td align="center" rowspan="1" colspan="1">28.2 &#x000b1; 12.0</td><td align="center" rowspan="1" colspan="1">28.2 &#x000b1; 11.0</td><td align="center" rowspan="1" colspan="1">26.4 &#x000b1; 10.5</td><td align="center" rowspan="1" colspan="1">27.8 &#x000b1; 9.9</td><td align="center" rowspan="1" colspan="1">26.8 &#x000b1; 10.7</td></tr><tr><td align="center" rowspan="1" colspan="1">21.4&#x02013;36.9</td><td align="center" rowspan="1" colspan="1">19.5&#x02013;36.8</td><td align="center" rowspan="1" colspan="1"> 20.2&#x02013;36.1</td><td align="center" rowspan="1" colspan="1">18.8&#x02013;33.9*</td><td align="center" rowspan="1" colspan="1">20.6&#x02013;34.9</td><td align="center" rowspan="1" colspan="1">19.1&#x02013;34.4</td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05; SD: standard deviation; CI: confidence interval; CF: Cardiac Frequency;
RF: Respiratory Frequency; PO<sub>2</sub>S: Peripheral oxygen saturation; MIP: Maximal
Inspiratory Pressure; MEP: Maximal Expiratory Pressure; PeakFlow: Expiratory Peak
Flow; Dynamometer: Peripheral Muscular Strength.</p></table-wrap-foot></table-wrap> shows significant decreases in the control group after the protocol period
including HR (p=0.04), MIP (p=0.04), MEP (p=0.06), peak flow (p=0.04), and dynamometry
(p=0.00) relative to the 5th session, and MIP (p=0.00), MEP (p=0.02) and peak flow (p=0.00)
relative to the 10th session using the paired t-test and Wilcoxon test.</p><p><xref rid="tbl_004" ref-type="table">Table 4</xref><table-wrap id="tbl_004" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Correlation between respiratory variables and peripheral muscle strength after
intervention</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="5" valign="middle" align="center">Sessions</th><th align="center" rowspan="1" colspan="1">Study group</th><th align="center" rowspan="1" colspan="1">Control group</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Dynamometer</th><th valign="top" align="center" rowspan="1" colspan="1">Dynamometer</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">r</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">1st</td><td align="left" valign="top" rowspan="1" colspan="1">MIP</td><td align="center" rowspan="1" colspan="1">0.79*</td><td align="center" rowspan="1" colspan="1">0.83*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MEP</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.64*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PeakFlow</td><td align="center" rowspan="1" colspan="1">0.74*</td><td align="center" rowspan="1" colspan="1">0.82*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">5th</td><td align="left" valign="top" rowspan="1" colspan="1">MIP</td><td align="center" rowspan="1" colspan="1">0.77*</td><td align="center" rowspan="1" colspan="1">0.90*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MEP</td><td align="center" rowspan="1" colspan="1">0.81*</td><td align="center" rowspan="1" colspan="1">0.67*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PeakFlow</td><td align="center" rowspan="1" colspan="1">0.64*</td><td align="center" rowspan="1" colspan="1">0.78*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">10th</td><td align="left" valign="top" rowspan="1" colspan="1">MIP</td><td align="center" rowspan="1" colspan="1">0.74*</td><td align="center" rowspan="1" colspan="1">0.83*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MEP</td><td align="center" rowspan="1" colspan="1">0.77*</td><td align="center" rowspan="1" colspan="1">0.64*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PeakFlow</td><td align="center" rowspan="1" colspan="1">0.65*</td><td align="center" rowspan="1" colspan="1">0.75*</td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05; MIP: Maximal Inspiratory Pressure; MEP: Maximal Expiratory Pressure;
PeakFlow: Expiratory Peak Flow; Dynamometer: Peripheral Muscular Strength.</p></table-wrap-foot></table-wrap>, shows positive correlations between the respiratory variables MIP (p=0.00)
and peak flow (p=0.01), and peripheral muscle strength at the 1st session; the MIP (p=0.00),
MEP (p=0.00) and peak flow (p=0.04) at the 5th session; and the MIP (p=0.01), MEP (p=0.00),
and peak flow (p=0.04) at the 10th session.</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>The respiratory system is affected by kidney disease and HD treatment. Alterations in the
muscular respiratory, mechanical ventilatory, and pulmonary gas exchange functions are
common in patients with CKD. This pulmonary dysfunction can be due to the direct effects of
circulating toxins or the indirect effects of volume overload, anemia, immunosuppression,
hypercalcemia, malnutrition and muscular weakness. Therefore, it is important to implement
respiratory muscular training exercises during HD treatment<xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>.</p><p>The present study showed the efficacy of a motor and respiratory physiotherapy protocol,
conducted during the first two hours of HD treatment. The patients in the study group showed
statistically significant improvements in muscular strength in all sessions compared with
the values obtained before and after physiotherapy. The expiratory peak flow was increased
at the 1st and 10th sessions relative to the pre- and post-physiotherapy values. Our
findings demonstrate the importance of a more individualized treatment protocol for CKD HD
patients.</p><p>Consistent with the present study, another study of 28 CKD HD patients showed increases in
the MIP and MEP when these measures were compared before and after physiotherapy. In this
study, motor physiotherapy consisted of warm-ups, stretching, and aerobic exercises, with
exercise cycles consisting of 60% of the maximal HR, as well as diaphragmatic breathing
pattern exercises<xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>.</p><p>However, the control group, which received only motor physiotherapy, showed significant
worsening of muscular strength at the 5th and 10th sessions. The expiratory peak flow in
this group was decreased in all sessions compared to the pre- and post-physiotherapy
values.</p><p>Additionally, in a non-randomized experimental study of 13 CKD HD patients, the respiratory
pressure (MIP and MEP) and expiratory peak flow were measured before and after physiotherapy
during HD treatment. Motor physiotherapy consisting of resistance exercises of the ULs and
LLs was conducted, but it did not result in significant improvements in the MIP and MEP.
However, the peak flow values were increased compared to pre- and post-physiotherapy
values<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>but this did not result in significant improvements in the MIP and MEP. However, the
PeakFlow values were increased compared the pre and post physiotherapeutic assistance
values<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>The mechanisms proposed in the literature to explain decreased respiratory muscular
strength result from uremic myopathy. These mechanisms include decreases in muscle mass
(transverse area section, mainly type II fibers), oxidative metabolism, muscular protein
synthesis, and plasma calcium concentration<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>.</p><p>In a cross-sectional observational study comparing respiratory muscular strength (MIP and
MEP) and expiratory forced flow (peak flow) in 32 CKD HD patients, with that of 30 healthy
individuals, decreases in respiratory muscular strength and peak flow were observed in the
patient group. These results showed that CKD HD patients exhibit respiratory muscular
strength dysfunction due to the conditions of the disease and the treatment<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>.</p><p>Another clinical study involving 15 CKD HD patients conducted inspiratory muscular training
with a Threshold Loaded IMT&#x000ae; provided by the hospital. The training protocol used 40% of the
MIP measured in the first session; however, no significant increases in MIP, MEP and expired
volume were observed after training<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>.</p><p>Another study in which the effect of a physiotherapy protocol using inspirometers in
patients with pleural effusion (a condition that affects patients with CKD) was evaluated
showed that at the time of admission, the parameters of the patients who received treatment
with respiratory support were lower than those of patients who received only drug treatment
and drainage. Moreover, radiological images showed an increase in lung expansion in the
intervention group compared to the control group<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>.</p><p>Therefore, the present study shows that motor and respiratory physiotherapy can minimize
the effects of uremic myopathy, and can improve pulmonary and muscular function and general
clinical status.</p><p>According to some authors, HD promotes systemic degradation of muscles and proteins. The
general muscular weakness observed in patients who undergo treatment predominately affects
the lower limbs and proximal musculature. The skeletal muscular system demonstrates the most
changes, including decreased physical capacity and reduced aerobic activity, in addition to
decreased peripheral muscular strength<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref><sup>)</sup>.</p><p>Studies have shown that stretching exercises are beneficial because they restore muscular
physiological length and elasticity, which can be very helpful for reducing the incidence of
cramps and minimizing the loss of muscle mass, in addition to promoting the necessary
strength for the individual to perform his or her daily activities<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>.</p><p>Peripheral muscular and grip strength are important measures used to evaluate global
muscular function. HD patients show compromised structural and muscular function, manifested
by atrophy and decreased proximal muscular strength<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref><sup>)</sup>.</p><p>A study of 43 patients undergoing HD treatment evaluated grip pressure strength, using a
dynamometer, before and after dialysis; the study determined that patients showed a distinct
loss of peripheral muscular strength<xref rid="r26" ref-type="bibr">26</xref><sup>)</sup>.</p><p>The present study showed an increase in peripheral muscular strength, which was measured by
the analog manual grip pressure in the ULs using a dynamometry device at the 10th session in
the study group, indicating that the proposed exercise protocol was effective in increasing
muscular strength.</p><p>The control group showed decreased peripheral muscular strength in all sessions; however, a
significant difference was only observed at the 5th session.</p><p>A study conducted on 13 CKD HD patients assessed peripheral muscular strength by measuring
manual grip in the upper limbs, with a dynamometer before and after physiotherapy. The study
used a protocol involving resistance exercises of the ULs and LLs for 24 sessions over two
months that were applied during the first two hours of HD. The results indicated worsening
of the dynamometry values after physiotherapy, but no significant difference was
observed<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>One of the factors that possibly contributed to the improvement of peripheral muscular
strength was the implementation of combined respiratory and motor physiotherapy. Increases
in peripheral muscle and respiratory muscular strength (MIP and MEP) were observed,
indicating that motor and respiratory exercises contributed to increasing global muscular
strength.</p></sec></body><back><ack><p>The author would like to acknowledge the fellowship awarded to the institution
(PIBICT/FAPEMIG) and the physicians and nurses of the Hemodialysis Sector of Casa da
Caridade Alfenas Nossa Senhora do Perp&#x000e9;tuo Socorro.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Stevens</surname><given-names>SL</given-names></name><name><surname>Stevens</surname><given-names>RJ</given-names></name><name><surname>Hobbs</surname><given-names>FR</given-names></name><etal>et al.</etal></person-group>: <article-title>Chronic renal disease is not chronic kidney disease:
implications for use of the QRISK and Joint British Societies risk
scores</article-title>. <source>Fam Pract</source>, <year>2016</year>,
<volume>33</volume>: <fpage>57</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="pmid">26585911</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Silva</surname><given-names>SF</given-names></name><name><surname>Pereira</surname><given-names>AA</given-names></name><name><surname>Silva</surname><given-names>WA</given-names></name><etal>et al.</etal></person-group>: <article-title>Fisioterapia durante a hemodi&#x000e1;lise de pacientes com doen&#x000e7;a
renal cr&#x000f4;nica</article-title>. <source>J Bras Neurol</source>, <year>2013</year>,
<volume>35</volume>: <fpage>170</fpage>&#x02013;<lpage>176</lpage>. </mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Bastos</surname><given-names>MG</given-names></name><name><surname>Bregman</surname><given-names>R</given-names></name><name><surname>Kirsztajn</surname><given-names>GM</given-names></name></person-group>: <article-title>Doen&#x000e7;a renal cr&#x000f4;nica: frequente e grave, mas tamb&#x000e9;m
prevenivel e trat&#x000e1;vel</article-title>. <source>AMB Rev Assoc Med Bras</source>,
<year>2010</year>, <volume>56</volume>: <fpage>248</fpage>&#x02013;<lpage>253</lpage>.
</mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Bae</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Jo</surname><given-names>JI</given-names></name></person-group>: <article-title>Aerobic training during hemodialysis improves body
composition, muscle function, physical performance, and quality of life in chronic
kidney disease patients</article-title>. <source>J Phys Ther Sci</source>,
<year>2015</year>, <volume>27</volume>: <fpage>1445</fpage>&#x02013;<lpage>1449</lpage>.
<pub-id pub-id-type="pmid">26157237</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Cury</surname><given-names>JL</given-names></name><name><surname>Brunetto</surname><given-names>AF</given-names></name><name><surname>Aydos</surname><given-names>RD</given-names></name></person-group>: <article-title>Negative effects of chronic kidney failure on lung
function and functional capacity</article-title>. <source>Rev Bras Fisioter</source>,
<year>2010</year>, <volume>14</volume>: <fpage>91</fpage>&#x02013;<lpage>98</lpage>.
<pub-id pub-id-type="pmid">20464163</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>B&#x000f6;hm</surname><given-names>J</given-names></name><name><surname>Monteiro</surname><given-names>MB</given-names></name><name><surname>Thom&#x000e9;</surname><given-names>FS</given-names></name></person-group>: <article-title>Efeitos do exerc&#x000ed;cio aer&#x000f3;bio durante a hemodi&#x000e1;lise em
pacientes com doen&#x000e7;a renal cr&#x000f4;nica: uma revis&#x000e3;o da literatura</article-title>. <source>J
Bras Neurol</source>, <year>2012</year>, <volume>34</volume>:
<fpage>189</fpage>&#x02013;<lpage>194</lpage>. </mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Rocha</surname><given-names>ER</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>SM</given-names></name><name><surname>Lima</surname><given-names>VP</given-names></name></person-group>: <article-title>Repercuss&#x000e3;o de um protocolo fisioterap&#x000ea;utico
intradial&#x000ed;tico na funcionalidade pulmonar, for&#x000e7;a de preens&#x000e3;o manual e qualidade de vida
de pacientes renais cr&#x000f4;nicos</article-title>. <source>J Bras Neurol</source>,
<year>2010</year>, <volume>32</volume>: <fpage>359</fpage>&#x02013;<lpage>371</lpage>.
</mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Prezant</surname><given-names>DJ</given-names></name></person-group>: <article-title>Effect of uremia and its treatment on pulmonary
function</article-title>. <source>Lung</source>, <year>1990</year>,
<volume>168</volume>: <fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="pmid">2105408</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="other"><person-group><name><surname>Lima</surname><given-names>FF</given-names></name><name><surname>Miranda</surname><given-names>RCV</given-names></name><name><surname>Silva</surname><given-names>RCR</given-names></name><etal>et al.</etal></person-group>: Avalia&#x000e7;&#x000e3;o funcional pr&#x000e9; e p&#x000f3;s programa de exerc&#x000ed;cio f&#x000ed;sico de pacientes
em hemodi&#x000e1;lise. Medicina (Ribeir&#x000e3;o Preto), <year>2013</year>, 46: 24&#x02013;35.</mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="other"><person-group><name><surname>Quintanilla</surname><given-names>AP</given-names></name><name><surname>Sahgal</surname><given-names>V</given-names></name></person-group>: Uremic myophaty. Inter J Artif Org, <year>1984</year>, 7:
239&#x02013;242.</mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Fahal</surname><given-names>IH</given-names></name><name><surname>Bell</surname><given-names>GM</given-names></name><name><surname>Bone</surname><given-names>JM</given-names></name><etal>et al.</etal></person-group>: <article-title>Physiological abnormalities of skeletal muscle in dialysis
patients</article-title>. <source>Nephrol Dial Transplant</source>, <year>1997</year>,
<volume>12</volume>: <fpage>119</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="pmid">9027785</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Adey</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>McCarthy</surname><given-names>JT</given-names></name><etal>et al.</etal></person-group>: <article-title>Reduced synthesis of muscle proteins in chronic renal
failure</article-title>. <source>Am J Physiol Endocrinol Metab</source>,
<year>2000</year>, <volume>278</volume>: <fpage>E219</fpage>&#x02013;<lpage>E225</lpage>.
<pub-id pub-id-type="pmid">10662705</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Cupisti</surname><given-names>A</given-names></name><name><surname>Licitra</surname><given-names>R</given-names></name><name><surname>Chisari</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Skeletal muscle and nutritional assessment in chronic
renal failure patients on a protein-restricted diet</article-title>. <source>J Intern
Med</source>, <year>2004</year>, <volume>255</volume>:
<fpage>115</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="pmid">14687247</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Tarasuik</surname><given-names>A</given-names></name><name><surname>Heimer</surname><given-names>D</given-names></name><name><surname>Bark</surname><given-names>H</given-names></name></person-group>: <article-title>Effect of chronic renal failure on skeletal and
diaphragmatic muscle contraction</article-title>. <source>Am Rev Respir Dis</source>,
<year>1992</year>, <volume>146</volume>: <fpage>1383</fpage>&#x02013;<lpage>1388</lpage>.
<pub-id pub-id-type="pmid">1456552</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Silva</surname><given-names>VG</given-names></name><name><surname>Amaral</surname><given-names>C</given-names></name><name><surname>Monteiro</surname><given-names>MB</given-names></name><etal>et al.</etal></person-group>: <article-title>Efeitos do treinamento muscular inspirat&#x000f3;rio nos pacientes
em hemodi&#x000e1;lise</article-title>. <source>J Bras Neurol</source>, <year>2011</year>,
<volume>33</volume>: <fpage>62</fpage>&#x02013;<lpage>68</lpage>. </mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Valenza-Demet</surname><given-names>G</given-names></name><name><surname>Valenza</surname><given-names>MC</given-names></name><name><surname>Cabrera-Martos</surname><given-names>I</given-names></name><etal>et al.</etal></person-group>: <article-title>The effects of a physiotherapy programme on patients with
a pleural effusion: a randomized controlled trial</article-title>. <source>Clin
Rehabil</source>, <year>2014</year>, <volume>28</volume>:
<fpage>1087</fpage>&#x02013;<lpage>1095</lpage>. <pub-id pub-id-type="pmid">24733648</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Martins</surname><given-names>MR</given-names></name><name><surname>Cestarino</surname><given-names>CB</given-names></name></person-group>: <article-title>Qualidade de vida de pessoas com doen&#x000e7;a renal cr&#x000f4;nica em
tratamento hemodial&#x000ed;tico</article-title>. <source>Rev Latinoam Enferm</source>,
<year>2005</year>, <volume>13</volume>: <fpage>670</fpage>&#x02013;<lpage>676</lpage>.
</mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Schardong</surname><given-names>JT</given-names></name><name><surname>Lukrafka</surname><given-names>LJ</given-names></name><name><surname>Garcia</surname><given-names>DV</given-names></name></person-group>: <article-title>Avalia&#x000e7;&#x000e3;o da fun&#x000e7;&#x000e3;o pulmonar e da qualidade de vida em
pacientes com doen&#x000e7;a renal cr&#x000f4;nica submetidos &#x000e0; hemodi&#x000e1;lise</article-title>. <source>J
Bras Neurol</source>, <year>2008</year>, <volume>30</volume>:
<fpage>40</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Perneger</surname><given-names>TV</given-names></name><name><surname>Leski</surname><given-names>M</given-names></name><name><surname>Chopard-Stoermann</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Assessment of health status in chronic hemodialysis
patients</article-title>. <source>J Nephrol</source>, <year>2003</year>,
<volume>16</volume>: <fpage>252</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="pmid">12768073</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>V&#x000e1;zquez</surname><given-names>I</given-names></name><name><surname>Valderr&#x000e1;bano</surname><given-names>F</given-names></name><name><surname>Jofr&#x000e9;</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>Spanish Cooperative Renal Patients Quality of Life Study Group:
<article-title>Psychosocial factors and quality of life in young hemodialysis patients
with low comorbidity</article-title>. <source>J Nephrol</source>, <year>2003</year>,
<volume>16</volume>: <fpage>886</fpage>&#x02013;<lpage>894</lpage>. <pub-id pub-id-type="pmid">14736017</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Figueiredo</surname><given-names>IM</given-names></name><name><surname>Sampaio</surname><given-names>RF</given-names></name><name><surname>Mancini</surname><given-names>MC</given-names></name><etal>et al.</etal></person-group>: <article-title>Teste de for&#x000e7;a de preens&#x000e3;o utilizando o dinam&#x000f4;metro
Jamar</article-title>. <source>Acta Fisiatrica</source>, <year>2007</year>,
<volume>14</volume>: <fpage>104</fpage>&#x02013;<lpage>110</lpage>.</mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Corr&#x000ea;a</surname><given-names>LB</given-names></name><name><surname>Oliveira</surname><given-names>RN</given-names></name><name><surname>Cantareli</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>: <article-title>Efeito do treinamento muscular perif&#x000e9;rico na capacidade
funcional e qualidade de vida nos pacientes em hemodi&#x000e1;lise</article-title>. <source>J
Bras Neurol</source>, <year>2009</year>, <volume>31</volume>:
<fpage>18</fpage>&#x02013;<lpage>24</lpage>.</mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Leal</surname><given-names>VO</given-names></name><name><surname>Stockler-Pinto</surname><given-names>MB</given-names></name><name><surname>Farage</surname><given-names>NE</given-names></name><etal>et al.</etal></person-group>: <article-title>Handgrip strength and its dialysis determinants in
hemodialysis patients</article-title>. <source>Nutrition</source>, <year>2011</year>,
<volume>27</volume>: <fpage>1125</fpage>&#x02013;<lpage>1129</lpage>. <pub-id pub-id-type="pmid">21454052</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Hirano</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name></person-group>: <article-title>Limits of the manipulative-fixed method for measurement of
shoulder joint horizontal adduction muscle strength using a handheld
dynamometer</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>235</fpage>&#x02013;<lpage>237</lpage>. <pub-id pub-id-type="pmid">25642081</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Sugiura</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Minatani</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Relationship between respiratory muscle strength and
exercise tolerance</article-title>. <source>J Phys Ther Sci</source>, <year>2009</year>,
<volume>21</volume>: <fpage>393</fpage>&#x02013;<lpage>397</lpage>. </mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Chatchawan</surname><given-names>U</given-names></name><name><surname>Jupamatangb</surname><given-names>U</given-names></name><name><surname>Chanchitc</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Immediate effects of dynamic sitting exercise on the lower
back mobility of sedentary young adults</article-title>. <source>J Phys Ther
Sci</source>, <year>2015</year>, <volume>27</volume>:
<fpage>3359</fpage>&#x02013;<lpage>3363</lpage>. <pub-id pub-id-type="pmid">26696698</pub-id></mixed-citation></ref></ref-list></back></article>